Butriptyline

Quality 0.50 · 2 views · Updated 2 months ago

Atypical tricyclic antidepressant medication

title: "Butriptyline" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["abandoned-drugs", "alpha-1-blockers", "dimethylamino-compounds", "dibenzocycloheptenes", "h1-receptor-antagonists", "muscarinic-antagonists", "serotonin-receptor-antagonists", "tricyclic-antidepressants"] description: "Atypical tricyclic antidepressant medication" topic_path: "arts/music" source: "https://en.wikipedia.org/wiki/Butriptyline" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Atypical tricyclic antidepressant medication ::

| Verifiedfields = changed | verifiedrevid = 447573132 | IUPAC_name = (±)-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine | image = Butriptyline.svg | image_class = skin-invert-image | width = 200px

| tradename = Evadyne, others | legal_AU = | legal_BR = C1 | legal_BR_comment = | legal_CA = | legal_DE = | legal_NZ = | legal_UK = | legal_US = | legal_EU = | legal_UN = | legal_status = Rx-only | routes_of_administration = Oral

| bioavailability = ? | protein_bound = 90% | metabolism = Hepatic (N-demethylation) | metabolites = Norbutriptyline | elimination_half-life = 20 hours | excretion =

| CAS_number_Ref = | CAS_number = 35941-65-2 | UNII_Ref = | UNII = Z22441975X

| index2_label = HCl | CAS_number2_Ref = | CAS_number2 = 5585-73-9 | UNII2_Ref = | UNII2 = LIJ2H8658W | ATC_prefix = N06 | ATC_suffix = AA15 | ChEBI_Ref = | ChEBI = 135227 | ChEMBL_Ref = | ChEMBL = 2110816 | PubChem = 21772 | DrugBank_Ref = | DrugBank = DB09016 | ChemSpiderID_Ref = | ChemSpiderID = 20462 | KEGG_Ref = | KEGG = D07601 | synonyms = AY-62014

| C=21 | H=27 | N=1 | SMILES = c1cc3c(cc1)CCc2c(cccc2)C3CC(C)CN(C)C | StdInChI_Ref = | StdInChI = 1S/C21H27N/c1-16(15-22(2)3)14-21-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)21/h4-11,16,21H,12-15H2,1-3H3 | StdInChIKey_Ref = | StdInChIKey = ALELTFCQZDXAMQ-UHFFFAOYSA-N | chirality = Racemic mixture

Butriptyline, sold under the brand name Evadyne among others, is a tricyclic antidepressant (TCA) that has been used in the United Kingdom and several other European countries for the treatment of depression but appears to no longer be marketed. Along with trimipramine, iprindole, and amoxapine, it has been described as an "atypical" or "second-generation" TCA due to its relatively late introduction and atypical pharmacology. It was very little-used compared to other TCAs, with the number of prescriptions dispensed only in the thousands.

Medical uses

Butriptyline was used in the treatment of depression. It was usually used at dosages of 150–300 mg/day.

Side effects

Butriptyline is closely related to amitriptyline, and produces similar effects as other TCAs, but its side effects like sedation are said to be reduced in severity and it has a lower risk of interactions with other medications.

Butriptyline has potent antihistamine effects, resulting in sedation and somnolence. It also has potent anticholinergic effects, resulting in side effects like dry mouth, constipation, urinary retention, blurred vision, and cognitive/memory impairment. The drug has relatively weak effects as an alpha-1 blocker and has no effects as a norepinephrine reuptake inhibitor, so is associated with little to no antiadrenergic and adrenergic side effects.

Overdose

Main article: Tricyclic antidepressant overdose

Pharmacology

Pharmacodynamics

::data[format=table title="Butriptyline{{cite web | title = PDSP Ki Database | work = Psychoactive Drug Screening Program (PDSP) | author1-link = Bryan Roth | vauthors = Roth BL, Driscol J | publisher = University of North Carolina at Chapel Hill and the United States National Institute of Mental Health | access-date = 14 August 2017 | url = https://pdsp.unc.edu/databases/pdsp.php?knowID=0&kiKey=&receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testLigandDD=&testFreeRadio=testFreeRadio&testLigand=butriptyline&referenceDD=&reference=&KiGreater=&KiLess=&kiAllRadio=all&doQuery=Submit+Query | archive-date = 2 December 2023 | archive-url = https://web.archive.org/web/20231202183736/https://pdsp.unc.edu/databases/pdsp.php?knowID=0&kiKey=&receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testLigandDD=&testFreeRadio=testFreeRadio&testLigand=butriptyline&referenceDD=&reference=&KiGreater=&KiLess=&kiAllRadio=all&doQuery=Submit+Query | url-status = live }}"]

SiteKi (nM)SpeciesRef
1,360
4,300
10,000 ()Human
Rat
Ratvauthors = Tatsumi M, Groshan K, Blakely RD, Richelson Etitle = Pharmacological profile of antidepressants and related compounds at human monoamine transportersjournal = European Journal of Pharmacology

| | | 5,100 990 1,700 (IC50) | Human Rat Rat |

| | | 3,940 2,800 5,200 (IC50) | Human Rat Rat |

| | 5-HT1A | 7,000 | Human | vauthors = Wander TJ, Nelson A, Okazaki H, Richelson E | title = Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro | journal = European Journal of Pharmacology | volume = 132 | issue = 2–3 | pages = 115–121 | date = December 1986 | pmid = 3816971 | doi = 10.1016/0014-2999(86)90596-0 }} | | 5-HT2A | 380 | Human | | | 5-HT2C | ND | ND | ND | | α1 | 570 | Human | | | α2 | 4,800 | Human | | | D2 | ND | ND | ND | | H1 | 1.1 | Human | vauthors = Richelson E, Nelson A | title = Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 230 | issue = 1 | pages = 94–102 | date = July 1984 | doi = 10.1016/S0022-3565(25)21446-X | pmid = 6086881 }} | | **** | 35 | Human | | | Values are Ki (nM), unless otherwise noted. The smaller the value, the more strongly the drug binds to the site. | | | | ::

In vitro, butriptyline is a strong antihistamine and anticholinergic, moderate 5-HT2 and α1-adrenergic receptor antagonist, and very weak or negligible monoamine reuptake inhibitor. These actions appear to confer a profile similar to that of iprindole and trimipramine with serotonin-blocking effects as the apparent predominant mediator of mood-lifting efficacy.

However, in small clinical trials, using similar doses, butriptyline was found to be similarly effective to amitriptyline and imipramine as an antidepressant, despite the fact that both of these TCAs are far stronger as both 5-HT2 antagonists and serotonin–norepinephrine reuptake inhibitors. As a result, it may be that butriptyline has a different mechanism of action, or perhaps functions as a prodrug in the body to a metabolite with different pharmacodynamics.

Pharmacokinetics

Therapeutic concentrations of butriptyline are in the range of 60–280 ng/mL (204–954 nmol/L). Its plasma protein binding is greater than 90%.

Chemistry

Butriptyline is a tricyclic compound, specifically a dibenzocycloheptadiene, and possesses three rings fused together with a side chain attached in its chemical structure. Other dibenzocycloheptadiene TCAs include amitriptyline, nortriptyline, and protriptyline. Butriptyline is an analogue of amitriptyline with an isobutyl side chain instead of a propylidene side chain. It is a tertiary amine TCA, with its side chain-demethylated metabolite norbutriptyline being a secondary amine. Other tertiary amine TCAs include amitriptyline, imipramine, clomipramine, dosulepin (dothiepin), doxepin, and trimipramine. The chemical name of butriptyline is 3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine and its free base form has a chemical formula of C21H27N with a molecular weight of 293.446 g/mol. The drug has been used commercially both as the free base and as the hydrochloride salt. The CAS Registry Number of the free base is 15686-37-0 and of the hydrochloride is 5585-73-9.

History

Butriptyline was developed by Wyeth and introduced in the United Kingdom in either 1974 or 1975.

Society and culture

Generic names

Butriptyline is the English and French generic name of the drug and its , , and , while butriptyline hydrochloride is its and . Its generic name in Latin is butriptylinum, in German is butriptylin, and in Spanish is butriptylina.

Brand names

Butriptyline has been marketed under the brand names Evadene, Evadyne, Evasidol, and Centrolese.

Availability

Butriptyline has been marketed in Europe, including in the United Kingdom, Belgium, Luxembourg, Austria, and Italy.

References

References

  1. Anvisa. (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial". [[Diário Oficial da União]].
  2. (4 February 2013). "Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds". John Wiley & Sons.
  3. (14 November 2014). "The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies". Springer.
  4. Swiss Pharmaceutical Society. (2000). "Index Nominum 2000: International Drug Directory (Book with CD-ROM)". Medpharm Scientific Publishers.
  5. William Andrew Publishing. (22 October 2013). "Pharmaceutical Manufacturing Encyclopedia". Elsevier.
  6. (16 April 2007). "Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application". Wiley.
  7. (1992). "Handbook of Affective Disorders". Guilford Press.
  8. (18 November 2009). "Textbook Of Pharmacology". Elsevier India.
  9. (2003). "Pharmacology". Elsevier India.
  10. (29 October 1982). "Handbook of Psychiatry: Volume 3, Psychoses of Uncertain Aetiology". CUP Archive.
  11. (2009). "Meyler's Side Effects of Psychiatric Drugs". Elsevier.
  12. (July 2007). "Tricyclic antidepressant pharmacology and therapeutic drug interactions updated". British Journal of Pharmacology.
  13. (1990). "Treatment of Chronic Pain: Possibilities, Limitations, and Long-term Follow-up". CRC Press.
  14. "PDSP Ki Database". University of North Carolina at Chapel Hill and the United States National Institute of Mental Health.
  15. (December 1997). "Pharmacological profile of antidepressants and related compounds at human monoamine transporters". European Journal of Pharmacology.
  16. (December 1986). "Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro". European Journal of Pharmacology.
  17. (July 1984). "Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro". The Journal of Pharmacology and Experimental Therapeutics.
  18. (February 1975). "Comparative pharmacological studies on butriptyline and some related standard tricyclic antidepressants". Canadian Journal of Physiology and Pharmacology.
  19. (August 1977). "Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression". Psychopharmacology.
  20. (September 1984). "Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake". European Journal of Pharmacology.
  21. (22 October 2013). "Drugs in Psychiatric Practice". Elsevier.
  22. (6 December 2012). "Forensic Science Progress". Springer Science & Business Media.
  23. (15 February 2013). "Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies". Springer Science & Business Media.
  24. (24 January 2012). "Foye's Principles of Medicinal Chemistry". Lippincott Williams & Wilkins.
  25. (20 September 1994). "Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology". John Wiley & Sons.
  26. (23 February 2012). "Metabolism of Drugs and Other Xenobiotics". John Wiley & Sons.
  27. (2002). "Pharmacology Secrets". Elsevier Health Sciences.
  28. (9 August 2012). "Shorter Oxford Textbook of Psychiatry". OUP Oxford.
  29. (11 November 2013). "Antidepressants for Elderly People". Springer.
  30. (2004). "Medical Toxicology". Lippincott Williams & Wilkins.
  31. (6 December 2012). "Concise Dictionary of Pharmacological Agents: Properties and Synonyms". Springer Science & Business Media.

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

abandoned-drugsalpha-1-blockersdimethylamino-compoundsdibenzocycloheptenesh1-receptor-antagonistsmuscarinic-antagonistsserotonin-receptor-antagoniststricyclic-antidepressants